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Between 1996 and 2006 a total of 278 patients with soft tissue Leiomyosarcoma were treated at our centre. We identiﬁed 16
patients (5.8%) where the tumour directly arose from the blood vessels. These tumours were studied to determine their prognosis
and behaviour. All tumors were in the lower limbs: 11 from the femoral vein, 3 popliteal vein, and 2 from the posterior tibial
vein. Mean tumour size was 10.4cm (3 to 33). Histological grade was high in all patients. Surgical treatment was amputation in
one, excision with or without vascular reconstruction in 12 followed by radiotherapy, and 3 patients had no surgery because of
advanced disease at diagnosis. Seven out of the 16 patients (44%) had metastasis at diagnosis, and ﬁve patients without metastasis
at diagnosis rapidly developed metastases at a median time of 5 months from diagnosis (2–30 months). The overall survival of the
patients at 5 years was 25% which was considerably worse than those with nonvascular leiomyosarcoma. We conclude that patients
with leiomyosarcoma of vascular origin have a very high risk of metastases and poor prognosis when treated in the conventional
way.
Copyright © 2009 R. Abed et al. This is an open access article distributed under the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Leiomyosarcomas arising directly from the blood vessels are
rare. Hence, there is limited publication and experience of
the clinical presentation and results of treating this type of
tumour. The tumours arise directly from the muscular wall
of either a major vein or artery. The majority of the tumours
arising in the extremities aﬀect the femoral vascular bundle
[1]. In general, leiomyosarcomas can be divided into three
types according to their site of origin [1]. Leiomyosarcomas
of soft tissues, being the most common [2], cutaneous
leiomyosarcoma having the best prognosis [3], and vascular
leiomyosarcomas.
Vascular leiomyosarcomas are deﬁned as any leiomyosar-
coma that arise from a major vessel based on clinical picture,
radiographic ﬁndings, and pathological ﬁndings [2]. There
are only a few reports of leiomyosarcomas of vascular origin
with the majority being isolated case reports [3–8]. There
is also controversy about the prognosis of patients with this
type of lieomyosarcoma [1, 9, 10]. The majority of patients
areatpresenttreatedlikemostsofttissuesarcomaswithlimb
preserving surgery and radiotherapy.
The aim of our study is to report our experience of
the clinical presentation, results of surgical treatment, and
oncological outcome of patients with vascular leiomyosar-
coma treated at a single supraregional oncology centre to
determine whether the current treatment protocol for this
tumour is adequate or not.
2.MaterialsandMethods
Between 1996 and 2006, 278 patients with leiomyosarcoma
were treated at our centre which is a supraregional centre for
the treatment of bone and soft tissue sarcomas. We identiﬁed
16 patients with leiomyosarcoma of vascular origin from the
prospectively collected orthopedic oncology database. The
minimumfollow-upwas12months.Thefollowinginforma-
tionwascollectedretrospectivelyfromthecaserecordsofthe
oncology database: the gender, age, presentation, duration of
complaint, grade of tumor, stage of disease, type of surgical
procedure,surgicalmargins,surgicalcomplications,whether
they had vascular reconstruction, any adjuvant treatment
such as radiotherapy or chemotherapy, follow up duration,
subsequent recurrence or metastasis, and condition of the
p a t i e n ta tp r e s e n t .
The tumour grade was according to the FNCLCC system
proposed by Trojani et al. [11] and the stage and margins
of resection were according to the Enneking staging system2 Sarcoma
Figure 1:MRIpictureofLeiomyosarcoma arisingfromthefemoral
vein.
[12]. Survival analysis was performed using Kaplan-Meier’s
method.
3. Results
3.1. Clinical Presentation. Of the 278 patients with
leiomyosarcoma of the extremities treated at our centre
over the study period, only 16 patients accounting for 5.8%
of the total were classiﬁed as vascular leiomyosarcomas.
There were 9 females and 7 males. The average age was 67
years (range 51–77). The tumours were located in the lower
extremity in all the patients arising from the femoral vein
in 11 patients (Figures 1 and 2), popliteal vein in three, and
posterior tibial vein in 2 patients.
Delay in diagnosis was common with eight patients
(50%) presenting with signiﬁcant leg swelling and edema
without any palpable soft tissue lump and clinically diag-
nosed as suﬀering from deep venous thrombosis. The
tumours were diagnosed in these patients during ultrasound
and/or venography performed to investigate them for deep
venous thrombosis. Six patients presented with lumps in
the groin, thigh, popliteal fossa, and ankle, two of these
underwent unplanned excision (“whoops procedure”) at
another institution prior to referral to our centre. One
patient presented with hemoptysis from lung metastasis, and
the tumour was only diagnosed during staging investiga-
tions. One patient presented with hematoma in the thigh.
Metastatic disease was evident in 7 patients (44%) at the
time of diagnosis. The clinical presentation of the patients
is summarized in Table 1.
Alltumourswerehighgrade(Figure 3).Theclinicalstage
of the disease at diagnosis was stage IIB in nine patients
(56%) and stage IIIB in 7 patients (44%). The tumor size
varied from 3 to 33cm (median 9cm).
3.2. Treatment. The treatment plan for each patient was
determined by a multidisciplinary team. Three patients with
advanced disease at diagnosis were treated with palliative
intent while 13 patients were treated with curative intent
with surgery involving resection and/or without vascular
Figure 2: Macroscopic picture of leiomyosarcoma of vascular
origin.
Figure 3: Miscroscopic picture of leiomyosarcoma arising from
major blood vessel.
reconstruction in these patients. Surgical treatment was
amputation in one and limb preserving in 12 patients.
Excision margins were classiﬁed as wide in 3 patients,
marginal in 7, and intralesional in 3 patients according to
the Musculoskeletal society classiﬁcation system [12]. There
was no failure of vascular reconstruction. One patient had
postoperative wound infection and necrosis which required
further surgery with wound debridement and irrigation.
Of the 12 patients with limb preservation, 7 required
excision of the main artery en bloc with the tumour and
vein in order to get clearance. Arterial reconstruction using
a vein interpositional graft was performed in these patients.
None of the patients had vein reconstruction as we often
tried to preserve the saphenous veins in these patients with
the hope that these would become the dominant venous
drainage. This was determined preoperatively, and the
surgery was done in collaboration with a vascular surgeon
who performed the reconstruction. In the remaining 5 cases
the resection included only the vein and no reconstruction
was done. This was possible in case of resection of the
femoralveinduetothepresenceofthesaphenousveinwhich
together with the collaterals compensated for the loss of the
femoral vein.
All patients who had resection had postoperative radio-
therapy, and two of the patients who did not have surgerySarcoma 3
Table 1: The clinical presentation in patients with leiomyosarcoma of vascular origin. NA = Not available.
Gender Age Presentation Location Size (cm) Grade Stage
F 55 Leg swelling Thigh NA 3 2B
F 74 Leg swelling Thigh 13 3 2B
M 67 Lump in ankle Ankle 3.5 2 2B
F 51 Hematoma in the thigh Thigh 33 3 3B
F 54 Lump in popliteal fossa Popliteal fossa 3 2 2B
M 60 Leg swelling Thigh 9 3 2B
M 67 Lump in groin Thigh NA 3 2B
M 68 Leg swelling Calf NA 2 2B
M 77 Leg swelling Popliteal fossa NA 3 3B
F 63 Thigh swelling Thigh NA 3 3B
F 63 Lump in popliteal fossa Popliteal fossa 13 3 3B
M 75 Lump in thigh Thigh 9 3 2B
M 72 Haemoptysis Thigh 9 3 3B
F 72 Lump in thigh Thigh 9.5 3 3B
F 68 Leg swelling Thigh 9 3 2B
F 75 Leg swelling Thigh 9 3 3B
had palliative radiotherapy. Two patients had postoperative
chemotherapy because of metastases at diagnosis.
3.3. Oncological Results. At the time of review, one patient
had died of lung carcinoma unrelated to the vascular
leiomyosarcoma.Threepatientswerealiveandfreeofdisease
at a mean time of 27 months (range 21–36), one was alive
withmetastasesand11haddiedofthediseaseatameantime
14 months (range 2–36). The cumulative overall survival
was 25% at 5 years. Of the patients with localized disease
at diagnosis, the cumulative metastases free disease was
33% and overall survival was 44% at 5 years. One patient
developed recurrence 5 months after hip disarticulation. The





In general, Leiomyosarcomas are uncommon tumors and
thought to have poor long-term prognosis. Svarvar et al.
reported on 225 patients with leiomyosarcoma of all types
from the Scandinavian Sarcoma Group with a cumulative
survival of 49% at 10 years [13].
Our study has focused speciﬁcally on Leiomyosarcomas
of vascular origin. Our experience conﬁrms that these
tumours are very rare, accounting for only 5.8% of all
patients with leiomyosarcoma treated at our centre. It is
therefore not surprising that experience in treating this type
of tumour is limited, and most reports in literature are
isolated case reports [3–8].
The largest series to date is from Kevorkian and Cento
who reported on 86 patients with leiomyosarcoma arising
from a major blood vessel in the 1970s [14]. The majority
of the tumours in their series arose in large-to-medium-
sized vessels 35 tumours (41%), 33 tumours (38%) arose
in the inferior vena cava, 10 tumours (12%) in the pul-
monary artery, and 8 tumours (9%) in the systemic arteries.
Dzsinich et al. [15]r e p o r t e do n1 3c a s e so fp r i m a r yv e n o u s
leiomyosarcoma. 8 of the 13 cases arose from the inferior
vena cava, 2 from the iliac vein, 1 from the ovarian vein, and
2 from the great saphenous vein.
The above series are diﬀerent from the patients in our
series in that we have only studied patients with extremity
vascular leiomyosarcomas. The outcome reported in our
series is very similar to those reported by Berlin et al. [1]wh o
studied 6 patients with leiomyosarcoma of venous origin in
theextremities.ThetumoursinBerlin’sserieswerelocatedin
the superﬁcial femoral vein in 3 cases, in the great saphenous
vein in one case, in the popliteal vein in one case, and in
the axillary vein in one case. Five patients in that series died
of metastatic disease, and one was still alive with metastatic
disease within 5 years of treatment.
The behaviour of vascular leiomyosarcomas has been
reported by other authors. Leu and Makek [9] reported good
prognosis on 5 cases of intramural venous leiomyosarcomas,
and Hadju [10] reported low metastatic potential. On the
other hand all the cases reported by Berlin et al. [1]h a d
metastases with 5 cases dying from metastatic disease within
5 years. The results of our series showed a very poor outcome
in vascular leiomyosarcoma with 75% of patients died of
metastatic disease within the ﬁrst 3 years of diagnosis,
although good local control by surgery and radiotherapy was
achieved. This is very similar to the series of Berlin et al. [1].
Our experience is that about half of the patients with
leiomyosarcomas of vascular origin had metastatic disease at
diagnosis which indicated either a very aggressive course of
thediseaseortheeﬀectsofdelayindiagnosisasmostpatients
had been thought to have deep venous thrombosis resulting
in diagnostic delay. Of the 9 patients without metastases at
diagnosis 5 patients developed metastases within 36 months
of the disease indicating that the tumours have an aggressive
clinical course. The cumulative survival at 5 years was rather4 Sarcoma
poor at 25%. It is unclear whether chemotherapy would have
made a diﬀerence in the prognosis of these patients. Only
two patients had chemotherapy and that was palliative for
metastatic disease.
Good local control can often be achieved with surgical
excision of the tumour with en-bloc resection of the vessels
combined with radiotherapy. Our experience also leads us
to believe that reconstruction of the vein is not necessary in
those cases where a major vein such as the long saphenous
vein in the lower limb can be preserved. This together with
collateral venous circulation is often enough for venous
drainage.Otherauthorshavereportedahighthrombosisrate
in those who undergo venous reconstruction [16].
We conclude that patients with leiomyosarcoma arising
from the blood vessels have a high risk of presenting
with metastases at the time of diagnosis or early after
diagnosis when treated in the conventional way used to treat
other soft tissue sarcomas. It is unclear whether a more
aggressive treatment regime will improve the prognosis of
these patients, and we believe that this can best be answered
by a multiinstitutional study using novel treatment strategy.
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